About
Jessie Nicodemus-Johnson is a biostatistician and biomedical researcher focused on Alzheimer's disease, biomarkers, and clinical-trial analysis. Pentara says she joined the company in 2020 as Senior Vice President of Biostatistics after earlier research work tied to the University of Chicago and a PhD in Molecular and Integrative Physiology from the University of Illinois Urbana-Champaign. Her publication record spans neurodegeneration, genomics, epigenetics, and translational clinical research.
Areas of interest
Alzheimer's diseasebiostatisticsclinical trialsbiomarkersneurodegenerative diseasegenomicsepigeneticshuman geneticsrespiratory diseasenutrition research